DALLAS, TX—The combination of endovascular revascularization plus supervised exercise therapy in patients with peripheral artery disease (PAD) and intermittent claudication results in greater ...

In patients with acute ischemic stroke undergoing contemporary endovascular therapy, timely treatment and achievement of successful revascularization are key to good functional outcome and reduced ...

Please provide your email address to receive an email when new articles are posted on . Fewer than half of veterans, most of whom were not on lipid-lowering therapy before an event, received ...

Please provide your email address to receive an email when new articles are posted on . After several decades associated with an evolving landscape for coronary revascularization and medical therapy, ...

During major vascular surgery, patients are at high risk for developing myocardial infarction and myocardial ischemia, and two risk-reduction strategies can be considered prior to surgery: ...

November 14, 2006 — A systematic review of studies of aggressive medical therapy vs angioplasty with stent placement for renal artery stenosis suggests similar kidney function outcomes but possibly ...

"For our patients with stable coronary artery disease on medical therapy, this means that 1 in 5 will realize a survival benefit about 5.5 years after revascularization and 1 in 4 will avoid a ...

Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk. (HealthDay News) — For patients ...

Revascularization is often performed in patients with stable ischemic heart disease (SIHD). However, whether revascularization reduces death and other cardiovascular outcomes is uncertain. Cumulative ...

Fractional flow reserve (FFR)-guided revascularization reduces the need for subsequent urgent revascularization in patients with stable coronary artery disease and functionally significant stenosis.

Phoenix, AZ (May 19, 2023)- New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent ...